Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

AI-driven diagnostic and prognostic models for metabolic dysfunction-associated steatotic liver disease: insights from clinical, imaging, and multi-omics studies—a scoping review

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is the most common chronic liver disease around the world, affecting 33.6% of the adult population (95% CI: 28.1%–39.5%; I2 = 99.9%), or roughly one in three. The extent of the liver damage is...

M. Sujana, G. Vivekananda · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.